Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study

BACKGROUND: The Systolic Blood Pressure Intervention Trial (SPRINT) showed significant reductions in death and cardiovascular disease (CVD) risk with a systolic blood pressure (SBP) goal of <120 mm Hg compared with a SBP goal of <140 mm Hg. Our study aimed to assess the applicability of SPRINT...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chao, Chen, Kangyu, Cornelius, Victoria, Tomeny, Ewan, Wang, Yang, Yang, Xiaowei, Yuan, Xiaodan, Qin, Rui, Yu, Dahai, Wu, Zhenqiang, Wang, Duolao, Chen, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971845/
https://www.ncbi.nlm.nih.gov/pubmed/33661907
http://dx.doi.org/10.1371/journal.pmed.1003515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971845/
https://www.ncbi.nlm.nih.gov/pubmed/33661907
http://dx.doi.org/10.1371/journal.pmed.1003515

Ejemplares similares